BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32162890)

  • 1. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
    Liu X; Li H
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
    Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
    Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J; Lu Q; Zhu J; Fu J; Chen YX
    Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].
    Li H; Bao HX; Qin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):476-483. PubMed ID: 32319382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of miR-34a in Bone Marrow of Adult Acute Lymphoblastic Leukemia and Its Significance in Cell Drug Resistance].
    Han B; Wang HX; Shao W; Han ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):336-40. PubMed ID: 27150988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of miR-155 in Acute Myeloid Leukemia and Its Clinical Significance].
    Hu XL; Tang AP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):980-4. PubMed ID: 27531760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
    Yu Z; Li D; Ju XL
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance.
    Wang XX; Zhang R; Li Y
    Med Sci Monit; 2017 Oct; 23():4768-4778. PubMed ID: 28978904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
    Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Serum miR-145 Predicts Poor Prognosis in Patients with Acute Myeloid Leukemia.
    Shi Q; Xing G; Qi M; Xing Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.